KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Retained Earnings (2016 - 2025)

Ionis Pharmaceuticals has reported Retained Earnings over the past 17 years, most recently at -$2.6 billion for Q4 2025.

  • Quarterly results put Retained Earnings at -$2.6 billion for Q4 2025, down 8439.79% from a year ago — trailing twelve months through Dec 2025 was -$2.6 billion (down 8439.79% YoY), and the annual figure for FY2025 was -$2.6 billion, down 8439.79%.
  • Retained Earnings for Q4 2025 was -$2.6 billion at Ionis Pharmaceuticals, down from -$26.0 million in the prior quarter.
  • Over the last five years, Retained Earnings for IONS hit a ceiling of -$24.2 million in Q3 2024 and a floor of -$2.6 billion in Q4 2025.
  • Median Retained Earnings over the past 5 years was -$611.5 million (2021), compared with a mean of -$891.0 million.
  • Peak annual rise in Retained Earnings hit 98.6% in 2025, while the deepest fall reached 8439.79% in 2025.
  • Ionis Pharmaceuticals' Retained Earnings stood at -$1.2 billion in 2021, then skyrocketed by 95.04% to -$57.5 million in 2022, then crashed by 3024.41% to -$1.8 billion in 2023, then surged by 98.28% to -$30.8 million in 2024, then plummeted by 8439.79% to -$2.6 billion in 2025.
  • The last three reported values for Retained Earnings were -$2.6 billion (Q4 2025), -$26.0 million (Q3 2025), and -$28.0 million (Q2 2025) per Business Quant data.